e-CHECKUP TO GO for Underage Drinking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests online programs aimed at reducing underage drinking among high school juniors and seniors. It examines a digital tool called e-CHECKUP TO GO, which provides teens with personalized feedback on their drinking habits, along with an additional program designed to help parents discuss alcohol with their children. The goal is to determine if these tools can lower alcohol use and its negative effects. Teens aged 15-18 and their parents who are part of Ipsos' Knowledge Panel are well-suited for this study. As an unphased trial, this study offers families a unique opportunity to contribute to innovative approaches in reducing underage drinking.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these interventions are safe for high school students?
Research has shown that the e-CHECKUP TO GO (eCTG) program helps reduce risky drinking among high school seniors. This online tool provides personalized feedback to help users understand their alcohol use and risks. The program has raised no safety concerns, as it is both informative and interactive.
Regarding the e-Parent Intervention combined with eCTG (eCTG+), studies indicate that involving parents can effectively reduce teen drinking. Teens whose parents used these tools reported drinking less and experiencing fewer alcohol-related issues.
Both programs focus on education and behavior change, not medication, so they are considered safe to use.12345Why are researchers excited about this trial?
Researchers are excited about these interventions for underage drinking because they leverage technology to directly engage both teens and their parents. e-CHECKUP TO GO (eCTG) is distinct as it provides a personalized, web-based program that gives teens feedback on their drinking habits, risk factors, and consequences, all accessible online for convenience and privacy. The eCTG+ adds another layer by incorporating an e-Parent Intervention, which equips parents with an electronic handbook to help them discuss alcohol use effectively with their teens. This dual approach targets the family unit, potentially addressing drinking behavior more comprehensively than traditional educational programs or counseling sessions.
What evidence suggests that this trial's treatments could be effective for reducing underage drinking?
Research has shown that the e-CHECKUP TO GO (eCTG) program, one of the interventions in this trial, reduces risky alcohol use among high school seniors. Studies indicate that this online program lowers teens' perceptions of peer drinking and decreases heavy drinking episodes. It also provides personalized feedback to help manage alcohol use.
Another intervention in this trial is the combined eCTG and e-Parent Intervention (eCTG+). Evidence suggests that involving parents can prevent or reduce teen drinking. This combination helps parents discuss alcohol and its effects with their teens, which can lead to less drinking. Overall, both the eCTG and eCTG+ programs in this trial have shown promise in effectively addressing underage drinking.24678Who Is on the Research Team?
Nadine Mastroleo, PhD
Principal Investigator
Binghamton University
Are You a Good Fit for This Trial?
This trial is for high school juniors and seniors aged 15-18 who, along with their parents, consent to participate. Both parent and teen form a 'dyad testing unit' and must be part of Ipsos' Knowledge Panel.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the eCHECKUP TO GO (eCTG) program, with some also receiving the e-Parent Intervention
Follow-up
Participants are monitored for changes in alcohol use and related behaviors
What Are the Treatments Tested in This Trial?
Interventions
- e-CHECKUP TO GO (eCTG)
- e-Parent Intervention and eCTG (eCTG+)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Binghamton University
Lead Sponsor